Most patients do not begin their cancer journey knowing much about nuclear medicine or expecting it to become part of their care. They arrive there because something has changed, and other imaging ...
In adult neuroendocrine malignancies, including small cell lung cancer, Delta-like ligand 3 (DLL3) is a validated therapeutic target. DLL3 is expressed in neuroblastoma, a pediatric cancer of ...
Journal of Nuclear Medicine June 2026, jnumed.126.272258; DOI: https://doi.org/10.2967/jnumed.126.272258 ...
Journal of Nuclear Medicine June 2026, jnumed.125.271600; DOI: https://doi.org/10.2967/jnumed.125.271600 ...
The gastrin-releasing peptide receptor (GRPR) is overexpressed in many solid malignancies, particularly in prostate and breast cancers, among others. We synthesized ProBOMB2, a novel bombesin ...
The adaptive immune response plays a critical role in detecting, eliminating, and creating a memory toward foreign pathogens and malignant cells. Demonstration of the specific and effective target ...
Journal of Nuclear Medicine June 2026, jnumed.126.272338; DOI: https://doi.org/10.2967/jnumed.126.272338 ...
Quantitative analysis has been applied extensively to image processing and interpretation in nuclear cardiology to improve disease diagnosis and risk stratification. This is Part 2 of a two-part ...
Dosimetry is integral to informed implementation of radiopharmaceutical therapies, enabling personalized treatment planning and ensuring patient safety by calculating absorbed doses to organs and ...
Cardiac PET is a versatile imaging technique providing important diagnostic information about ischemic heart diseases. Respiratory and cardiac motion of the heart can strongly impair image quality and ...
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and professional organization founded in 1954 to promote the science, technology, and practical application ...
Bone metastases are common, especially in more prevalent malignancies such as breast and prostate cancer. They cause significant morbidity and draw on health-care resources. Molecular and hybrid ...